Evidence-Based Medicine Guidelines
Golimumab for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Golimumab for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/Golimumab_for_rheumatoid_arthritis.
Golimumab for rheumatoid arthritis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/Golimumab_for_rheumatoid_arthritis. Accessed December 2, 2024.
Golimumab for rheumatoid arthritis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/Golimumab_for_rheumatoid_arthritis
Golimumab for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/Golimumab_for_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Golimumab for rheumatoid arthritis
ID - 457010
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/Golimumab_for_rheumatoid_arthritis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
